Jay Fawver
Psychiatry · Angola, INNPI 1164457404
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $945,149 of the $1,420,274 with a category attached, or 66.5%. 31 manufacturers reported payments, led by Johnson & Johnson at 46.4% of the total. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,574 payments — averaging $902.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$659K
- Axsome Therapeutics, Inc.$379K
- Alkermes, Inc.$258K
- Takeda Pharmaceuticals U.S.A., Inc.$57K
- Biogen$26K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$17K
- plus $23K from 25 others
What the payments were for
- Consulting fees$250,70018%
- Speaking & faculty fees$945,14967%
- Travel & lodging$197,99314%
- Food & beverage$26,3282%
- Education$1040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 648 | $659,406 |
| Axsome Therapeutics, Inc. | 281 | $379,387 |
| Alkermes, Inc. | 302 | $258,023 |
| Takeda Pharmaceuticals U.S.A., Inc. | 102 | $56,885 |
| Biogen | 36 | $25,932 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $17,339 |
| H. Lundbeck A S | 4 | $12,463 |
| Janssen Scientific Affairs, LLC | 12 | $4,701 |
| Sage Therapeutics, LLC | 3 | $3,774 |
| Lundbeck LLC | 20 | $291 |
| Neurocrine Biosciences, Inc. | 15 | $243 |
| Otsuka America Pharmaceutical, Inc. | 7 | $241 |
| Sunovion Pharmaceuticals Inc. | 18 | $234 |
| Vanda Pharmaceuticals Inc. | 12 | $233 |
| Bausch Health US, LLC | 14 | $199 |
| Adlon Therapeutics L.p. | 13 | $165 |
| AbbVie(2 entities) | 10 | $149 |
| Teva Pharmaceuticals USA, Inc. | 7 | $113 |
| Arbor Pharmaceuticals, Inc. | 5 | $77 |
| Shire North American Group Inc | 5 | $73 |
| Eisai Inc. | 5 | $66 |
| Jazz Pharmaceuticals Inc. | 3 | $52 |
| Corium, LLC | 3 | $51 |
| Avanir Pharmaceuticals, Inc. | 3 | $39 |
| Merck | 2 | $29 |
| Noven Therapeutics, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Novartis | 1 | $15 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,013,883
- SPRAVATO$657,783
- Auvelity$376,676
- TRINTELLIX$41,377
- Zurzuvae$25,265
- CAPLYTA$16,382
- VYVANSE$13,615
- BRINTELLIX$12,463
- REXULTI$124
How this compares
$1,420,274 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 11 | $9,355 |
| Trazodone Hcl | 21 | $528 |
| Gabapentin | 38 | $500 |
| Lamotrigine | 20 | $228 |
| Bupropion XlBupropion Hcl | 12 | $207 |
| Duloxetine Hcl | 13 | $185 |
| Pregabalin | 12 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $56,885 | $9,35511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Angola
- Teresa GreinerAngola$6K
- Steven PaulCarmel$2.9M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
- Muhammad MunirAnderson$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.